Jalil, Lilma K.

HRN: 25-17-16  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/01/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/01/2024
06/08/2024
IV
4.5g
Q8h
CAP-MR

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Non-compliant To Guidelines